Retraction
Inhibition of histone deacetylase activity promotes invasion of human cancer cells through activation of urokinase plasminogen activator
Paper Information
Record ID:
24232
Journal:
Publication Date:
October 08, 2007
Retraction Date:
September 01, 2020
(5.2 years years ago)
Subjects:
Institutions:
Country:
🇺🇸 United StatesArticle Type:
Publisher:
American Society for Biochemistry and Molecular Biology (ASBMB)
Open Access:
Yes
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (53)
53
Total Citations2
Post-Retraction(3.8%)
50
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
1
Within 1 year
1
After 2+ years
824
Days since retraction (latest)
Paper citing Expression of antisense uPAR and antisense uPA fro...
Unknown Authors
Unknown Journal
Published: Unknown
Nafamostat Mesylate in Combination with the Mouse Amino-Terminal Fragment of Urokinase–Human Serum Albumin Improves the Treatment Outcome of Triple-Negative Breast Cancer Therapy
Yang Zhou, Shujuan Yu, Dan Chen et al. (8 authors)
Molecular Pharmaceutics
Published: Dec 2022
6 citations
6 citations
824 days after retraction
Inhibition of phospholipase D2 augments histone deacetylase inhibitor-induced cell death in breast cancer cells
Won Chan Hwang, Dong Woo Kang, Youra Kang et al. (6 authors)
Biological Research
Open Access
Published: Sep 2020
10 citations
10 citations
29 days after retraction
Molecular Determinants of Cancer Therapy Resistance to HDAC Inhibitor-Induced Autophagy
Maria Mrakovcic, Leopold F. Fröhlich
Cancers
Open Access
Published: Dec 2019
36 citations
36 citations
245 days before retraction
Regulation of HDACi−Triggered Autophagy by the Tumor Suppressor Protein p53
Maria Mrakovcic, Leopold F. Fröhlich
IntechOpen eBooks
Open Access
Published: Jun 2019
1 citation
1 citation
432 days before retraction
The hopeful anticancer role of oleuropein in breast cancer through histone deacetylase modulation
Neda Mansouri, Mohammad Reza Alivand, Sahar Bayat et al. (5 authors)
Journal of Cellular Biochemistry
Published: May 2019
18 citations
18 citations
468 days before retraction
p53 at the Crossroads between Different Types of HDAC Inhibitor-Mediated Cancer Cell Death
Maria Mrakovcic, Johannes Kleinheinz, Leopold F. Fröhlich
International Journal of Molecular Sciences
Open Access
Published: May 2019
76 citations
76 citations
475 days before retraction
Antimetastatic effect of epigenetic drugs, hydralazine and valproic acid, in Ras-transformed NIH 3T3 cells
Enrique Pérez‐Cárdenas, Lucía Taja‐Chayeb, Catalina Trejo‐Becerril et al. (9 authors)
OncoTargets and Therapy
Open Access
Published: Dec 2018
5 citations
5 citations
640 days before retraction
Divergent JNK Phosphorylation of HDAC3 in Triple-Negative Breast Cancer Cells Determines HDAC Inhibitor Binding and Selectivity
Thomas W. Hanigan, Shaimaa M. Aboukhatwa, Taha Y. Taha et al. (5 authors)
Cell chemical biology
Open Access
Published: Sep 2017
32 citations
32 citations
1076 days before retraction
Acetylation is essential for nuclear heme oxygenase-1-enhanced tumor growth and invasiveness
F-F Hsu, M-T Chiang, Fu‐An Li et al. (6 authors)
Oncogene
Open Access
Published: Aug 2017
33 citations
33 citations
1100 days before retraction
The role of REST and HDAC2 in epigenetic dysregulation of Nav1.5 and nNav1.5 expression in breast cancer
Nur Sabrina Kamarulzaman, Hemaniswarri Dewi Dewadas, Chiuan Yee Leow et al. (5 authors)
Cancer Cell International
Open Access
Published: Aug 2017
35 citations
35 citations
1127 days before retraction
Histone deacetylase inhibitors induce invasion of human melanoma cells in vitro via differential regulation of N-cadherin expression and RhoA activity
María Díaz-Núñez, Alejandro Díez-Torre, Olivier De Wever et al. (7 authors)
BMC Cancer
Open Access
Published: Aug 2016
26 citations
26 citations
1471 days before retraction
Metal-dependent Deacetylases: Cancer and Epigenetic Regulators
Jeffrey E. López, Eric D. Sullivan, Carol A. Fierke
ACS Chemical Biology
Open Access
Published: Feb 2016
36 citations
36 citations
1651 days before retraction
The urokinase-type plasminogen activator (uPA) system as a biomarker and therapeutic target in human malignancies
Shih‐Chi Su, Chiao‐Wen Lin, Wei‐En Yang et al. (5 authors)
Expert Opinion on Therapeutic Targets
Published: Dec 2015
136 citations
136 citations
1723 days before retraction
Gene expression profiling of circulating tumor cells and peripheral blood mononuclear cells from breast cancer patients
Michal Hensler, Irena Vančurová, Étienne Becht et al. (12 authors)
OncoImmunology
Open Access
Published: Dec 2015
36 citations
36 citations
1727 days before retraction
The Histone‐Deacetylase‐Inhibitor Suberoylanilide Hydroxamic Acid Promotes Dental Pulp Repair Mechanisms Through Modulation of Matrix Metalloproteinase‐13 Activity
Henry F. Duncan, Anthony J. Smith, Garry J.P. Fleming et al. (7 authors)
Journal of Cellular Physiology
Open Access
Published: Aug 2015
35 citations
35 citations
1848 days before retraction
Inhibition of breast cancer progression by a novel histone deacetylase inhibitor, <scp>LW</scp>479, by down‐regulating <scp>EGFR</scp> expression
Jingjie Li, Tao Zhang, Feifei Yang et al. (9 authors)
British Journal of Pharmacology
Open Access
Published: Apr 2015
14 citations
14 citations
1964 days before retraction
New and emerging HDAC inhibitors for cancer treatment
Alison C. West, Ricky W. Johnstone
Journal of Clinical Investigation
Open Access
Published: Jan 2014
1275 citations
1275 citations
2435 days before retraction
Transforming Growth Factor-Beta and Urokinase-Type Plasminogen Activator: Dangerous Partners in Tumorigenesis—Implications in Skin Cancer
Juan F. Santibáñez
ISRN Dermatology
Open Access
Published: Jul 2013
50 citations
50 citations
2602 days before retraction
ABCD2 Is a Direct Target of β-Catenin and TCF-4: Implications for X-Linked Adrenoleukodystrophy Therapy
Chul‐Yong Park, Han-Soo Kim, Jiho Jang et al. (8 authors)
PLoS ONE
Open Access
Published: Feb 2013
17 citations
17 citations
2749 days before retraction
Expression of activation-induced cytidine deaminase in oral epithelial dysplasia and oral squamous cell carcinoma
Yuji Miyazaki, Masahiro Fujinami, Harumi Inoue et al. (6 authors)
Journal of Oral Science
Open Access
Published: Jan 2013
3 citations
3 citations
2800 days before retraction
O envolvimento da remodelação da cromatina no controle do comportamento agressivo dos carcinomas epidermoides de cabeça e pescoço
Fernanda Salgueiredo Giudice
Unknown Journal
Open Access
Published: Dec 2012
2822 days before retraction
Histone deacetylases and cancer
Bruna Barneda‐Zahonero, Maribel Parra
Molecular Oncology
Open Access
Published: Aug 2012
423 citations
423 citations
2927 days before retraction
HDAC Inhibitors Augmented Cell Migration and Metastasis through Induction of PKCs Leading to Identification of Low Toxicity Modalities for Combination Cancer Therapy
Kuen‐Tyng Lin, Yiwei Wang, Chiung‐Tong Chen et al. (6 authors)
Clinical Cancer Research
Open Access
Published: Jul 2012
80 citations
80 citations
2966 days before retraction
Histone deacetylase inhibitor, apicidin, inhibits human ovarian cancer cell migration via class II histone deacetylase 4 silencing
Mee Young Ahn, Dong Oh Kang, Yong Jin Na et al. (10 authors)
Cancer Letters
Published: Jul 2012
49 citations
49 citations
2978 days before retraction
Expression of HDAC1 in leukemia cells
Himani Sethi
Unknown Journal
Published: May 2012
3038 days before retraction
Tissue Factor Pathway Inhibitor-2 Inhibits the Growth and Invasion of Hepatocellular Carcinoma Cells and is Inactivated in Human Hepatocellular Carcinoma
Yong Xu, Xiaolin Qin, Jinjing Zhou et al. (8 authors)
InTech eBooks
Open Access
Published: Feb 2012
11 citations
11 citations
3126 days before retraction
Inhibition of Histone Deacetylase Activity in Human Endometrial Stromal Cells Promotes Extracellular Matrix Remodelling and Limits Embryo Invasion
Carlos Estella, Isabel Herrer, Stuart P. Atkinson et al. (7 authors)
PLoS ONE
Open Access
Published: Jan 2012
61 citations
61 citations
3141 days before retraction
The histone deacetylase inhibitor trichostatin A induces cell cycle arrest and rapid upregulation of gadd45β in LS174T human colon cancer cells
Tomoyuki Taniguchi, Jun Iwashita, Jun Murata et al. (5 authors)
Advances in Biological Chemistry
Open Access
Published: Jan 2012
1 citation
1 citation
3166 days before retraction
PKD2 and PKD3 Promote Prostate Cancer Cell Invasion via uPA by Shifting Balance Between NF-κB and HDAC1
Zhipeng Zou, Fangyin Zeng, Wanfu Xu et al. (7 authors)
Journal of Cell Science
Open Access
Published: Jan 2012
82 citations
82 citations
3166 days before retraction
Activation-induced cytidine deaminase mRNA expression in oral squamous cell carcinoma-derived cell lines is upregulated by inflammatory cytokines
Yuji Miyazaki, Harumi Inoue, Kentaro Kikuchi et al. (5 authors)
Journal of Oral Science
Open Access
Published: Jan 2012
7 citations
7 citations
3166 days before retraction
Histone deacetylase inhibitors upregulate MMP11 gene expression through Sp1/Smad complexes in human colon adenocarcinoma cells
Juan I. Barrasa, Nieves Olmo, Angélica Santiago-Gómez et al. (7 authors)
Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Open Access
Published: Dec 2011
22 citations
22 citations
3169 days before retraction
Epigenetic Biomarkers in Melanoma
Suhu Liu, Suping Ren, Paul Howell et al. (4 authors)
Springer eBooks
Published: Nov 2011
3210 days before retraction
Paper citing Recombinant adeno‐associated virus (rAAV) expressi...
Unknown Authors
Unknown Journal
Published: Jul 2011
3346 days before retraction
Tissue factor pathway inhibitor-2 inhibits the growth and invasion of hepatocellular carcinoma cells and is inactivated in human hepatocellular carcinoma
Yong Xu
Oncology Letters
Open Access
Published: Jul 2011
18 citations
18 citations
3346 days before retraction
Epigenetic Regulation of Asthma and Allergic Diseases
Andrew Durham, Ian M. Adcock
Springer eBooks
Published: Jan 2011
2 citations
2 citations
3531 days before retraction
Epigenetic Aspects of Chronic Diseases
Helmtrud I. Roach, Félix Bronner, Richard O. C. Oreffo
Springer eBooks
Published: Jan 2011
21 citations
21 citations
3531 days before retraction
Acetylation of EGF receptor contributes to tumor cell resistance to histone deacetylase inhibitors
Hui Song, Chia‐Wei Li, Adam M. LaBaff et al. (16 authors)
Biochemical and Biophysical Research Communications
Open Access
Published: Nov 2010
45 citations
45 citations
3573 days before retraction
Preparation and evaluation of tributyrin emulsion as a potent anti-cancer agent against melanoma
Sung Nam Kang, Eunmyong Lee, Mi‐Kyung Lee et al. (4 authors)
Drug Delivery
Published: Oct 2010
28 citations
28 citations
3610 days before retraction
Epigenetic Upregulation of Urokinase Plasminogen Activator Promotes the Tropism of Mesenchymal Stem Cells for Tumor Cells
Sai Murali Krishna Pulukuri, Bharathi Gorantla, Venkata Ramesh Dasari et al. (5 authors)
Molecular Cancer Research
Open Access
Published: Jul 2010
31 citations
31 citations
3688 days before retraction
Anticancer effects of the MHY218 novel hydroxamic acid-derived histone deacetylase inhibitor in human ovarian cancer cells
Kim
International Journal of Oncology
Open Access
Published: Jun 2010
9 citations
9 citations
3723 days before retraction
Inhibition of histone deacetylase activity down-regulates urokinase plasminogen activator and matrix metalloproteinase-9 expression in gastric cancer
Kyung Hee Lee, Eun Young Choi, Min Kyoung Kim et al. (9 authors)
Molecular and Cellular Biochemistry
Published: Jun 2010
31 citations
31 citations
3729 days before retraction
Journal of Cancer Science & Therapy
Unknown Authors
Journal of Cancer Science & Therapy
Published: Apr 2010
20 citations
20 citations
3790 days before retraction
Naturally Occurring Regulators of Histone Acetylation/Deacetylation
Florence Folmer, Barbora Orlikova, Michaël Schnekenburger et al. (5 authors)
Current Nutrition & Food Science
Published: Feb 2010
33 citations
33 citations
3865 days before retraction
Frequent loss of cystatin E/M expression implicated in the progression of prostate cancer
Sai Murali Krishna Pulukuri, Bharathi Gorantla, James A. Knost et al. (4 authors)
Oncogene
Open Access
Published: Jun 2009
40 citations
40 citations
4103 days before retraction
Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion
Sophie Iochmann, Claire Bléchet, Valérie Chabot et al. (8 authors)
Clinical & Experimental Metastasis
Published: Mar 2009
42 citations
42 citations
4196 days before retraction
The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Salvatore Ulisse, Enke Baldini, Salvatore Sorrenti et al. (4 authors)
Current Cancer Drug Targets
Published: Jan 2009
302 citations
302 citations
4232 days before retraction
Radiosensitizing Potential of Epigenetic Anticancer Drugs
Harlinde De Schutter, Sandra Nuyts
Anti-Cancer Agents in Medicinal Chemistry
Published: Jan 2009
37 citations
37 citations
4261 days before retraction
Neprilysin gene expression requires binding of the amyloid precursor protein intracellular domain to its promoter: implications for Alzheimer disease
Nikolai D. Belyaev, Natalia N. Nalivaeva, Natalia Z. Makova et al. (4 authors)
EMBO Reports
Open Access
Published: Dec 2008
167 citations
167 citations
4288 days before retraction
Epigenetic marks in melanoma
Hunter W. Richards, Estela E. Medrano
Pigment Cell & Melanoma Research
Published: Nov 2008
26 citations
26 citations
4296 days before retraction
Quick Stats
Total Citations:
53
Years Since Retraction:
5.2 years
Open Access:
Yes
Last Checked:
Jul 24, 2025